The phrase “Ozempic babies” entered common usage for a reason. Enough people have become unexpectedly pregnant while taking GLP-1 medications that it became a recognised phenomenon — and for many of them, nobody had raised the possibility.
There are two separate mechanisms at work, and conflating them causes confusion. The first is well established: GLP-1s can restore fertility in people whose fertility was reduced by weight or by conditions such as PCOS. The second is genuinely contested: whether these medications reduce the effectiveness of oral contraception.
On that second point, the evidence does not line up neatly, and we are not going to pretend otherwise. One study suggested GLP-1 receptor agonists could cut the efficacy of oral contraception; this has been queried in another study. Other analysis indicates that for semaglutide, a meaningful reduction in oral contraceptive effectiveness has not been demonstrated.
What is not contested is that this conversation should happen before you start, not after. This article sets out what is established, what is disputed, and what to raise with your clinician.
What Is Established and What Is Not
Established: Fertility Can Improve
Reporting from University Hospitals notes that for some women GLP-1s can boost fertility by improving overall health. Weight loss and metabolic improvement can restore ovulation in people for whom it had become irregular, including in PCOS.
Established: GLP-1s Are Not for Use in Pregnancy
These medications are not recommended during pregnancy. If you become pregnant while taking one, that is a conversation to have with your clinician promptly rather than at your next scheduled appointment.
Contested: Effect on Oral Contraceptives
One study suggested GLP-1 receptor agonists could cut oral contraception efficacy, and that has been queried in another study. Separate analysis indicates research suggests semaglutide does not significantly affect how the body absorbs oral contraceptives.
Plausible: GI Side Effects Affecting Absorption
A mechanism raised in reporting is that gastrointestinal side effects — nausea, vomiting and diarrhoea — can decrease absorption of an oral pill. This is a general principle for oral contraception rather than something unique to GLP-1s.
Molecule-Specific Differences May Exist
Evidence and labelling differ between molecules. Analysis has noted differences in how semaglutide and tirzepatide are treated on this question, so guidance for one should not be assumed to apply to the other.
The Conversation Frequently Does Not Happen
The most consistent theme in reporting on unplanned pregnancies during GLP-1 treatment is that patients were not warned. That is the practical failure this article exists to address.
Why Fertility Can Return
This is the better-established of the two mechanisms and probably the more common explanation for unexpected pregnancies.
Excess weight and conditions such as polycystic ovary syndrome can disrupt ovulation. Substantial weight loss and improved metabolic health can restore it. Published work notes that fertility outcomes may improve with GLP-1 receptor agonists and dual GLP-1/GIP agonists due to weight loss and related metabolic benefits.
For someone who has experienced irregular cycles or difficulty conceiving for years, and who may reasonably have concluded that pregnancy was unlikely, the return of regular ovulation can be genuinely unexpected. If contraception was not being used carefully on that assumption, pregnancy can follow quickly.
This is not a side effect in the ordinary sense. For patients trying to conceive, it may be a welcome outcome, and GLP-1s are being studied in that context. The problem is specifically that it happens to people who were not expecting it and were not told it might.
PCOS Is the Clearest Case
Polycystic ovary syndrome is strongly associated with both weight and ovulatory dysfunction. Improvement in one frequently improves the other, which makes restored fertility a realistic prospect for this group specifically.
It Can Happen Quickly
Reporting describes people finding themselves part of an unexpected baby boom. Restored ovulation does not wait for you to reach a goal weight — it can occur relatively early in treatment.
If You Are Trying to Conceive, Discuss Timing
GLP-1s are not recommended during pregnancy, so patients hoping to conceive need a plan for stopping in advance rather than discovering the issue later. That is a clinical discussion worth having early.
The Contraception Question, Honestly
Here the evidence is genuinely mixed, and you will find confident claims in both directions online. Neither is well supported.
The case for concern: Reporting notes that one study suggested GLP-1 receptor agonists could cut the efficacy of oral contraception. A plausible mechanism is that GI side effects — nausea, vomiting, diarrhoea — can decrease absorption of an oral pill. US News coverage of GLP-1s and reproductive health lists reduced effectiveness of oral birth control among the effects discussed.
The case against: That same reporting notes the finding has been queried in another study. Analysis published by Clue states research suggests semaglutide does not significantly affect how the body absorbs oral contraceptives, and that this is also true for other GLP-1 medications. Hertility Health states that for semaglutide, a meaningful reduction in oral contraceptive effectiveness has not been demonstrated.
What follows from that: not a definitive answer, but a clear practical implication. The absorption mechanism is real and general — any significant vomiting or diarrhoea can affect an oral pill’s reliability, whatever caused it. During GLP-1 titration, those symptoms are common. That alone is worth planning around, regardless of how the molecule-specific question eventually resolves.
Vomiting and Diarrhoea Affect Any Oral Pill
This is standard contraceptive guidance and not specific to GLP-1s: significant vomiting or diarrhoea can reduce absorption. Since these are among the most common GLP-1 side effects during titration, the interaction is worth taking seriously on general principles alone.
Molecule-Specific Guidance Differs
Evidence and product labelling are not identical across semaglutide, tirzepatide and other agents. Do not assume guidance for one applies to another — ask about the specific medication you are taking.
Non-Oral Methods Sidestep the Question
The absorption concern applies specifically to oral contraception. Methods that do not depend on gastrointestinal absorption are not subject to it. Whether switching is appropriate is a clinical decision, but it is a reasonable question to raise.
What to Raise With Your Clinician
Whether you are starting a GLP-1, already on one, or thinking about pregnancy, these are the conversations worth having explicitly.
1. Could my fertility change on this medication?
Ask directly, particularly if you have PCOS, irregular cycles, or a history of difficulty conceiving. The answer may change your contraceptive planning.
2. Is my current contraception appropriate alongside this?
Raise the oral absorption question specifically, and mention how much nausea or GI upset you are experiencing. The evidence is contested, but your symptoms are a concrete input.
3. What should I do if I vomit after taking my pill?
This is standard contraceptive guidance that becomes considerably more relevant during GLP-1 titration. Know the answer before you need it, not after.
4. What if I want to become pregnant?
GLP-1s are not recommended in pregnancy, so this requires planning in advance — how long before trying to conceive should you stop, and what happens to your weight and metabolic health in the interim.
5. What do I do if I become pregnant while taking this?
Have this answer before it is a live question. Contact your clinician promptly rather than waiting for a scheduled appointment.
Our Take
The single most useful thing in this article is that the conversation should happen at all. The consistent theme across reporting on unplanned pregnancies during GLP-1 treatment is not that the science was unclear — it is that patients were never told fertility might change. A five-minute discussion at the start of treatment addresses most of the risk.
Take restored fertility seriously as the more established mechanism. GLP-1s improving fertility through weight loss and metabolic improvement is better supported than the contraception-absorption question, and it is probably the more common explanation. If you have PCOS or irregular cycles and are not seeking pregnancy, plan contraception accordingly.
On oral contraception, we are not going to give you false certainty. One study suggested reduced efficacy; another queried it; analysis of semaglutide specifically indicates no meaningful reduction has been demonstrated. What is not in doubt is that significant vomiting or diarrhoea can affect any oral pill — and those symptoms are common during titration. That is enough to warrant a conversation without needing the underlying question settled.
If you become pregnant while taking a GLP-1, contact your clinician promptly. These medications are not recommended in pregnancy, and that is a decision to make with a doctor rather than by reading a website. Our guide on managing side effects covers the GI symptoms that sit underneath much of this.
Frequently Asked Questions
What are “Ozempic babies”?
It is the informal term for unplanned pregnancies occurring during GLP-1 treatment. Two mechanisms are discussed: restored fertility from weight loss and metabolic improvement, which is well established, and possible reduced effectiveness of oral contraception, which is contested. Reporting describes people finding themselves part of an unexpected baby boom.
Do GLP-1s make you more fertile?
They can. University Hospitals reporting notes that for some women GLP-1s can boost fertility by improving overall health, and published work indicates fertility outcomes may improve with GLP-1 and dual GLP-1/GIP agonists due to weight loss and related metabolic benefits. This is most relevant for people whose fertility was affected by weight or conditions such as PCOS.
Do GLP-1s make birth control less effective?
The evidence is genuinely contested. One study suggested GLP-1 receptor agonists could cut oral contraception efficacy, and that has been queried in another study. Analysis published by Clue indicates research suggests semaglutide does not significantly affect absorption of oral contraceptives, and Hertility Health states a meaningful reduction has not been demonstrated for semaglutide. Discuss your specific medication with your clinician.
Why might GLP-1s affect oral contraception?
The mechanism raised in reporting is that gastrointestinal side effects — nausea, vomiting and diarrhoea — can decrease absorption of an oral pill. That is a general principle of contraceptive guidance rather than something unique to GLP-1s, but it is relevant because those symptoms are common during titration.
Should I switch to non-oral contraception?
The absorption concern applies specifically to oral methods, so methods not dependent on gastrointestinal absorption are not subject to it. Whether switching is appropriate for you is a clinical decision — but it is a reasonable question to raise with your clinician, particularly if you are experiencing significant nausea or vomiting.
Can I take a GLP-1 while pregnant?
GLP-1 medications are not recommended during pregnancy. If you become pregnant while taking one, contact your clinician promptly rather than waiting for a scheduled appointment. Do not make decisions about continuing or stopping based on information from a website.
What if I am trying to conceive?
Because GLP-1s are not recommended in pregnancy, this requires planning in advance rather than reacting later. Discuss with your clinician how far ahead of trying to conceive you should stop, and what that means for your weight and metabolic health in the interim.
Does this apply to tirzepatide as well as semaglutide?
Evidence and labelling differ between molecules, and analysis has noted differences in how the two are treated on the contraception question. Do not assume guidance for one applies to the other — ask specifically about the medication you are taking.
Disclosure:
This article is based on publicly available information including reporting from University Hospitals, US News & World Report, Clue and Hertility Health on GLP-1s and reproductive health, published work indexed in academic journals on GLP-1 receptor agonists and fertility outcomes, and clinical commentary on unplanned pregnancy risk flagged for GLP-1s, current as of August 2026. The evidence on whether GLP-1 medications reduce oral contraceptive effectiveness is genuinely contested and we have presented it as such rather than resolving it. Presidential GLP-1 may receive compensation from some providers featured on this site, which helps us provide free, independent reviews. Nothing here is medical advice. Contraceptive and pregnancy decisions belong entirely to you and a clinician who knows your history — if you become pregnant while taking a GLP-1, contact your clinician promptly. We do not sell, dispense, or ship medication.
⚕ Medical Disclaimer:
This article is for informational purposes only and is not medical advice. Prescription weight-management medications carry serious risks and contraindications; GLP-1 receptor agonists carry a boxed warning for thyroid C-cell tumors. Only a licensed clinician who knows your medical history can determine whether any weight-management medication is appropriate for you. See our full medical disclaimer.
Related Guides & Articles
Managing GLP-1 Side Effects
The nausea, vomiting and GI symptoms that sit underneath the absorption question.
Best GLP-1 Providers for Women
Providers oriented around women’s health, where these conversations are more likely to happen.
GLP-1 Eligibility
Who these medications are and are not appropriate for.
Stopping GLP-1 Medications
What happens when treatment ends, relevant if you are planning a pregnancy.
Compare All GLP-1 Providers
Read our independent reviews of every provider we cover
View All Reviews →